Impact of omitting clinical target volume in radiotherapy for locally advanced non-small cell lung cancer: a propensity score matching analysis

Omitting the CTV was associated with a decrease of grade ≥3 radiation-induced toxicities without pejorative impact on PFS or OS in LA-NSCLC patients treated with IMRT. Furthermore, no increase in regional or metastatic recurrence rates were observed. This radiotherapy strategy may be a viable option for selected LA-NSCLC patients, reducing toxicities without compromising outcomes.

Authors

Institutions

Publication Details

Journal
Translational Lung Cancer Research
Published
2025-05-01
DOI
https://doi.org/10.21037/tlcr-2025-409
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of omitting clinical target volume in radiotherapy for locally advanced non-small cell lung cancer: a propensity score matching analysis

Petros Christopoulos, Baptiste Abbar, Wen Bao, Ying Zhang et al.
Translational Lung Cancer Research
Lung Cancer Treatments and Mutations
article

Impact of omitting clinical target volume in radiotherapy for locally advanced non-small cell lung cancer: a propensity score matching analysis

Petros Christopoulos, Baptiste Abbar, Wen Bao, Ying Zhang, Yaoyao Zhu, Liang Liu, Qian Cheng, Xiaoshuai Yuan, Shuangyan Yang, Yaping Xu
article en

Abstract

Omitting the CTV was associated with a decrease of grade ≥3 radiation-induced toxicities without pejorative impact on PFS or OS in LA-NSCLC patients treated with IMRT. Furthermore, no increase in regional or metastatic recurrence rates were observed. This radiotherapy strategy may be a viable option for selected LA-NSCLC patients, reducing toxicities without compromising outcomes.

Translational Lung Cancer ResearchVol. 14(5)
Tongji University (CN), Heidelberg University (DE), Fudan University (CN), University Hospital Heidelberg (DE), Zhongshan Hospital (CN), Shanghai Pulmonary Hospital (CN), German Center for Lung Research (DE)
Good health and well-being
Openalex Percentile: Top 80%
Lung Cancer Treatments and Mutations
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Impact of omitting clinical target volume in radiotherapy for locally advanced non-small cell lung cancer: a propensity score matching analysis — Petros Christopoulos, Baptiste Abbar, et al. · Translational Lung Cancer Research (2025) | TGRS Research Map | TGRS